Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways ; volume:16 ; number:1 ; day:24 ; month:4 ; year:2017 ; pages:1-11 ; date:12.2017
Malaria journal ; 16, Heft 1 (24.4.2017), 1-11, 12.2017
- Keyword
-
Nichtmedikamentöse Therapie
- Creator
-
Chaccour, Carlos
- Contributor
-
Rabinovich, N. Regina
SpringerLink (Online service)
- DOI
-
10.1186/s12936-017-1803-2
- URN
-
urn:nbn:de:1111-201705052996
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chaccour, Carlos
- Rabinovich, N. Regina
- SpringerLink (Online service)
Other Objects (12)
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ivermectin metabolites reduce Anopheles survival
Author Correction: Ivermectin metabolites reduce Anopheles survival
Solution Oligonucleotide APIs: Regulatory Considerations
Ivermectin and abamectin
Ethical and regulatory aspects regarding xenotransplantation
Some considerations regarding budgetary priorities during crisis
Ivermectin and malaria control
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
Religion, gender, and social welfare: considerations regarding inclusion
Some considerations regarding the problem of multidimensional utility
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ivermectin metabolites reduce Anopheles survival
Author Correction: Ivermectin metabolites reduce Anopheles survival
Solution Oligonucleotide APIs: Regulatory Considerations
Ivermectin and abamectin
Ethical and regulatory aspects regarding xenotransplantation
Some considerations regarding budgetary priorities during crisis
Ivermectin and malaria control
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
Religion, gender, and social welfare: considerations regarding inclusion
Some considerations regarding the problem of multidimensional utility
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
Ivermectin metabolites reduce Anopheles survival
Author Correction: Ivermectin metabolites reduce Anopheles survival
Solution Oligonucleotide APIs: Regulatory Considerations
Ivermectin and abamectin
Ethical and regulatory aspects regarding xenotransplantation
Some considerations regarding budgetary priorities during crisis
Ivermectin and malaria control
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
Religion, gender, and social welfare: considerations regarding inclusion